Humana Inc: Form 10-Q for the period ended Sep 30, 2010
Filed with the SEC on Nov 1, 2010 and accepted by EDGAR at Nov 1, 2010, 16:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2010-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2010-07-01 to 2010-09-30 | $8.42bn | us-gaap:Revenues |
| Revenue | 9 months2010-01-01 to 2010-09-30 | $25.52bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2010-07-01 to 2010-09-30 | $1.07bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2010-01-01 to 2010-09-30 | $3.36bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2010-07-01 to 2010-09-30 | $648.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2010-01-01 to 2010-09-30 | $1.65bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2010-07-01 to 2010-09-30 | $26.1m | us-gaap:InterestExpense |
| Interest expense | 9 months2010-01-01 to 2010-09-30 | $78.7m | us-gaap:InterestExpense |
| Income tax | 3 months2010-07-01 to 2010-09-30 | $229.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2010-01-01 to 2010-09-30 | $583.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2010-07-01 to 2010-09-30 | $393.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2010-01-01 to 2010-09-30 | $992.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2010-07-01 to 2010-09-30 | $2.32 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2010-01-01 to 2010-09-30 | $5.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2010-07-01 to 2010-09-30 | $2.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2010-01-01 to 2010-09-30 | $5.90 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2010-07-01 to 2010-09-30 | 169,582,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2010-01-01 to 2010-09-30 | 169,964,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2010-01-01 to 2010-09-30 | $2.29bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2010-01-01 to 2010-09-30 | $152.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2010-01-01 to 2010-09-30 | $108.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2010-09-30 | $2.92bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2010-09-30 | $11.38bn | us-gaap:AssetsCurrent |
| Total assets | At period end2010-09-30 | $16.39bn | us-gaap:Assets |
| Current liabilities | At period end2010-09-30 | $6.26bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2010-09-30 | $9.45bn | us-gaap:Liabilities |
| Long-term debt | At period end2010-09-30 | $1.67bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2010-09-30 | $6.94bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2010-09-30 | 168,318,547 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-10-242671. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.